|
In an era of rapid pharmaceutical development and complex global clinical trials, the need for a common medical language has never been more urgent. In a landmark educational initiative, the Indian Clinical Trial and Education Network, under the aegis of the Indian Council of Medical Research (ICMR), is set to host a pivotal webinar titled "Introduction to MedDRA: Standardizing Medical Terms in Clinical Trials."
Scheduled for June 20, 2025, from 4:00 PM to 5:00 PM IST, this virtual session aims to demystify MedDRA (Medical Dictionary for Regulatory Activities), a globally recognized terminology used to harmonize medical information in regulatory communication and clinical research.
Dr. Anamika Dutt, medical officer at MedDRA Maintenance and Support Services Organization (MSSO), a leading authority in the field of medical standardization, will lead the core session from 4:05 PM to 4:50 PM. The session will offer insights into how MedDRA enhances the clarity, consistency, and reliability of data across trials—facilitating faster regulatory approvals, improving pharmacovigilance, and ultimately safeguarding patient health.
The session will begin with a welcome address by Dr. Aparna Mukherjee, Scientist F and Head of Clinical Studies & Trials Unit (CSTU) and Regional Medical Research Centres (RCN) at ICMR HQ, who will underscore the significance of unified medical terminologies in India's evolving clinical research landscape.
In clinical trials, disparate interpretations of adverse events and medical conditions can lead to miscommunication, delays, or even trial failure. MedDRA provides a standardized vocabulary that allows for seamless international collaboration—vital in today’s multi-centre, multi-country trial models.
With India’s role in clinical research expanding, understanding and implementing MedDRA is no longer optional but essential. Dr. Dutt’s session is expected to provide clarity not only for regulators and researchers but also for healthcare professionals striving to maintain data integrity.
MedDRA is an internationally used set of terms relating to medical conditions, medicines and medical devices. It was created to assist regulators with sharing information.
MSSO is responsible for maintaining, developing, and distributing the MedDRA medical terminology. It's a global organization that supports users, including regulatory authorities, pharmaceutical companies, and other stakeholders, in using and understanding the MedDRA.
|